SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
Clin Pediatr (Phila)
.
2023 Jul;62(7):683-687.
doi: 10.1177/00099228221141534.
Epub 2022 Dec 10.
Authors
Bobby L Boyanton Jr
1
2
,
Jessica N Snowden
3
4
5
6
,
Rachel A Frenner
1
,
Eric R Rosenbaum
1
2
,
Heather L Young
5
6
,
Joshua L Kennedy
7
8
Affiliations
1
Department of Pathology, Arkansas Children's Hospital, Little Rock, AR, USA.
2
Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
3
Departments of Pediatrics and Biostatistics, Arkansas Children's Hospital, Little Rock, AR, USA.
4
Departments of Pediatrics and Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
5
Department of Infectious Diseases, Arkansas Children's Hospital, Little Rock, AR, USA.
6
Department of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
7
Departments of Pediatrics and Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
8
Arkansas Children's Research Institute, Little Rock, AR, USA.
PMID:
36495165
PMCID:
PMC9747366
DOI:
10.1177/00099228221141534
No abstract available
MeSH terms
COVID-19*
Humans
Pharyngitis* / drug therapy
SARS-CoV-2
Streptococcal Infections* / diagnosis
Streptococcal Infections* / prevention & control
Streptococcus pyogenes